肝动脉化疗栓塞治疗原发性肝癌临床疗效评价  

作　　者：史铭[1] 李韧[1] 布洁[1] 

机构地区：[1]武警总医院肿瘤一科,北京100039

出　　处：《临床医药文献电子杂志》2014年第17期2446-2446,2448,共2页Electronic Journal of Clinical Medical Literature

摘　　要：目的分析和研究肝动脉化疗栓塞治疗原发性肝癌临床疗效。方法选取我院2012年3月~2014年1月原发性肝癌患者38例,按治疗方法不同将其分为观察组21例与对照组17例。对照组患者仅给予手术治疗;观察组患者在术后加用肝动脉化疗栓塞治疗,将两组患者生存率与复发率进行对比。结果两组患者2年内生存率相比较：观察组高于对照组对比差异具有统计学意义（P〈0.05）;两组患者2年内复发率相比较：观察组低于对照组对比差异具有统计学意义（P〈0.05）。结论将肝动脉化疗栓塞方法应用于原发性肝癌患者治疗中,能够有效提高患者生存时间,对延缓病情发展及提高患者生存质量均有重要意义。Objective To analyze and research the clinical curative effect of hepatic arterial chemo embolization of primary liver cancer.Selection Methods Our hospital in March 2012 - January 2014,38 patients with primary liver cancer, according to the different treatments will be divided into the observation group of 21 cases of 17 cases with control group.Control group patients give only surgery; Observation group of patients with hepatic artery embolism chemotherapy after surgery treatment,two groups of patients survival rate and recurrence rate were compared. Results Two groups of patients compared 2 years survival rate： observation group is higher than the control group （P〈0.05）; Compared two groups of patients with recurrence 2 years： observation group is lower than the control group （P〈 0.05）. Conclusion The method of hepatic artery embolism chemotherapy is used in the treatment of patients with primary liver cancer, can effectively improve the patients survival time,to slow disease progression and improve quality of life of patients.

关 键 词：肝动脉化疗栓塞 原发性肝癌 生存时间 复发率 

分 类 号：R735.7[医药卫生—肿瘤]